Ver mas grande
MYO18A antibody
FT-FNab08686
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IHC |
| Target | MYO18A |
| Research Area | Signal Transduction |
| Form | liquid |
| Recomended Dilution | WB: 1:500-1:2000 |
| Type Clonality | polyclonal |
| Immunogen | TGFB1-induced anti-apoptotic factor 1 |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | Putative TGFB1-induced anti-apoptotic factor 1|12 kDa TGF-beta-1-induced antiapoptotic factor|MYO18A|TIAF1 |
| Host | Rabbit |
| UniProt ID | O95411 |
| Gene ID | 9220 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human |
| Observed MW | 12 kDa |
| Background | Inhibits the cytotoxic effects of TNF-alpha and overexpressed TNF receptor adapters TRADD, FADD, and RIPK1. Involved in TGF-beta1 inhibition of IkappaB-alpha expression and suppression of TNF-mediated IkappaB-alpha degradation. |
Más información
TIAF1 antibody